Premier Alternatives

Tahoe

Drug Discovery · South San Francisco, CA · Founded 2022 · Privately Held (backing)

Operator of a biotech company intended to combine data to find better targets and drugs that can treat patients. Tahoe is based in South San Francisco, CA and was founded in 2022. It was valued at $131 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $50 million across 1 recorded round; the latest was a $35 million Series A in Aug 2025.

PMV mark · valuation
$131.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$50.0M
Last round
Early Stage VC (Series A)
Aug 2025
How much has Tahoe raised?
$50.0Macross 1 recorded rounds · Aug 2025 – Aug 2025

Most recently, Tahoe raised $35.0M in its Early Stage VC (Series A) (Aug 2025).

Free account
More of Tahoe with a free account
  • ·The complete investor list: 12 names
  • ·Watch Tahoe: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Tahoe round by round

1 rounds
Aug 2025Early Stage VC (Series A)$35.0M▮
+ 1 more investors · free account

How much has Tahoe raised?

Tahoe has raised $50 million in total; 1 of its rounds is on record. The largest on record was a $35 million Series A in Aug 2025.

Tahoe investors

12 investors are on record for Tahoe, including General Catalyst, Mubadala Investment Company, AWS Startups and Wing Venture Capital. By type, the record holds 9 venture capital firms. The Series A in Aug 2025 drew 8 investors.

For fundraisers
Raising for a company like Tahoe?

12 investors have backed Tahoe — start your target list with the firms already writing checks in drug discovery.

See all 12 investors →

Frequently asked about Tahoe

How much has Tahoe raised?
Tahoe has raised $50.0M in total across 1 recorded funding rounds.
When was Tahoe's last funding round?
Tahoe's most recent recorded round was Early Stage VC (Series A) in Aug 2025, raising $35.0M.